Mukilteo Beacon - Your Hometown News Source

By Jana Hill 

Vaccine research continues

 

Last updated 11/29/2020 at 7:44pm



Multiple vaccines are being studied for prevention of COVID-19 and one of them is being considered for emergency use for high-risk populations, by the end of the year.

Pfizer's COVID-19 vaccine is under review by the FDA on Dec. 10. If approved for emergency use, it could be made available to high- risk populations by the end of December. The World Health Organization reports that 15% of COVID-19 infections are "severe infection, requiring oxygen and 5% are critical infections, requiring ventilation."

On Dec. 10, Pfizer intends to present information to the FDA that includes safety data fro...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021